Scholarly Index
Ravi Vij
Washington University in St. Louis; 27,072 total citations; 839 total publications; best world rank #94
Washington University in St. Louis
27,072Total citations
839Total publications
73H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 94 | US 52 | 99.34 |
| Protein Degradation and Inhibitors | Lifetime | 106 | US 62 | 99.04 |
| Peptidase Inhibition and Analysis | Lifetime | 339 | US 157 | 98.67 |
| Cancer Treatment and Pharmacology | Lifetime | 588 | US 295 | 98.41 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 439 | US 237 | 98.28 |
| Acute Myeloid Leukemia Research | Lifetime | 732 | US 332 | 98.07 |
| Ubiquitin and proteasome pathways | Lifetime | 844 | US 411 | 96.70 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 954 | US 398 | 96.19 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 96 | US 47 | 98.73 |
| Protein Degradation and Inhibitors | 2021-2025 | 178 | US 86 | 96.01 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 467 | US 154 | 93.22 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 248 | US 97 | 84.27 |
| Chemokine receptors and signaling | 2021-2025 | 444 | US 80 | 64.65 |